Crossmark

The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic

Crossref DOI link: https://doi.org/10.1038/s41574-020-0386-0

Published Online: 2020-08-06

Published Print: 2020-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Geng, Leiluo https://orcid.org/0000-0003-2886-3476
Lam, Karen S. L.

Xu, Aimin https://orcid.org/0000-0002-0668-033X
License Information

Text and Data Mining valid from 2020-08-06

Version of Record valid from 2020-08-06
More Information

Article History

Accepted: 26 June 2020

First Online: 6 August 2020

Competing interests

: The authors declare no competing interests.